Bionomics Limited to Participate in the Cantor Neurology & Psychiatry Conference
October 04, 2022 06:00 ET
|
Bionomics Ltd
ADELAIDE, Australia, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX | ASX: BNO) (Bionomics or Company), a clinical-stage biopharmaceutical company developing novel, allosteric ion...
Bionomics to Host KOL Webinar on BNC210 and Social Anxiety Disorder
September 21, 2022 06:00 ET
|
Bionomics Ltd
ADELAIDE, Australia, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX:BNO, Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biopharmaceutical company developing novel, allosteric ion...
Bionomics to Participate in Upcoming September Investor Conferences
August 31, 2022 06:00 ET
|
Bionomics Ltd
ADELAIDE, Australia, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX:BNO Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biopharmaceutical company developing novel, allosteric ion...
Bionomics reports Full Year Financial Results
August 25, 2022 06:00 ET
|
Bionomics Ltd
ADELAIDE, Australia, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX:BNO, Nasdaq:BNOX), today announced its financial results for the 12 months ended 30 June 2022. Bionomics is a clinical...
Bionomics Receives R&D Tax Incentive Refund for FY2021 of A$2.1M
August 08, 2022 06:00 ET
|
Bionomics Ltd
ADELAIDE, Australia, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX: BNO, NASDAQ:BNOX), a clinical stage biopharmaceutical company, is pleased to announce that the Company has received...
Quarterly Activities Report for June 2022
July 29, 2022 06:00 ET
|
Bionomics Ltd
ADELAIDE, Australia, July 29, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX | ASX: BNO) (Bionomics or Company), a global, clinical stage biopharmaceutical company, today released its...
Bionomics to Participate in William Blair’s Biotech Focus Conference 2022
July 08, 2022 06:00 ET
|
Bionomics Ltd
ADELAIDE, Australia, July 08, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX | ASX: BNO) (Bionomics or Company), a clinical-stage biopharmaceutical company developing novel, allosteric ion...
Bionomics Limited to Participate in the H.C. Wainwright Mental Health Conference
June 27, 2022 06:00 ET
|
Bionomics Ltd
ADELAIDE, Australia, June 27, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX | ASX: BNO) (Bionomics or Company), a clinical-stage biopharmaceutical company developing novel, allosteric ion...
Bionomics Investor Webinar
June 13, 2022 16:30 ET
|
Bionomics Ltd
ADELAIDE, Australia, June 13, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX: BNO |Nasdaq: BNOX ), (Bionomics or the Company), a clinical-stage biopharmaceutical company developing novel,...
Bionomics Limited to Participate in Upcoming Investor Conferences
May 16, 2022 06:00 ET
|
Bionomics Ltd
ADELAIDE, Australia, May 16, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX | ASX: BNO) (Bionomics or Company), a clinical-stage biopharmaceutical company developing novel, allosteric ion...